Skip to content
2000
Volume 28, Issue 14
  • ISSN: 1386-2073
  • E-ISSN: 1875-5402

Abstract

Background

Precancerous Lesions of Gastric Cancer (PLGC) are critical in the secondary prevention of gastric cancer. Despite the notable effects of natural products on PLGC, the specific mechanisms by which compounds, like 6-gingerol, influence these lesions are not fully understood.

Aims

This study aimed to confirm the effect and mechanism of 6-gingerol in the treatment of precancerous lesions of gastric cancer (PLGC).

Objective

The objective of this study was to elucidate the effects and mechanisms of 6-gingerol against PLGC using network pharmacology and experiments.

Methods

We employed network pharmacology to identify potential targets and pathways influenced by 6-gingerol, followed by validation through experiments using a PLGC cell model.

Results

Network pharmacology analysis highlighted the PI3K/Akt signaling pathway as significantly influenced by 6-gingerol. experiments confirmed that 6-gingerol effectively inhibited proliferation, invasion, and metastasis of MC cells, promoted apoptosis, and induced cell cycle arrest, primarily through modulation of the PI3K/Akt pathway. Statistical analysis revealed significant inhibition ( < 0.05) across these cellular processes in a dose-dependent manner.

Conclusion

This study demonstrated that 6-gingerol acts as an effective agent against PLGC, with clear dose-dependent effects that pave the way for further experimental and clinical exploration.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cchts/10.2174/0113862073303380240722112207
2024-07-29
2025-11-03

  • From This Site

    /content/journals/cchts/10.2174/0113862073303380240722112207
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. WangZ. HanW. XueF. ZhaoY. WuP. ChenY. YangC. GuW. JiangJ. Nationwide gastric cancer prevention in China, 2021–2035: A decision analysis on effect, affordability and cost-effectiveness optimisation.Gut202271122391240010.1136/gutjnl‑2021‑325948 35902213
     [Google Scholar]
  2. GuanW.L. HeY. XuR.H. Gastric cancer treatment: Recent progress and future perspectives.J. Hematol. Oncol.20231615710.1186/s13045‑023‑01451‑3 37245017
     [Google Scholar]
  3. BattistaS. AmbrosioM.R. LimarziF. GalloG. SaragoniL. Molecular alterations in gastric preneoplastic lesions and early gastric cancer.Int. J. Mol. Sci.20212213665210.3390/ijms22136652 34206291
     [Google Scholar]
  4. GulloI. GrilloF. MastracciL. VanoliA. CarneiroF. SaragoniL. LimarziF. FerroJ. ParenteP. FassanM. Precancerous lesions of the stomach, gastric cancer and hereditary gastric cancer syndromes.Pathologica2020112316618510.32074/1591‑951X‑166 33179620
     [Google Scholar]
  5. LageJ. UedoN. Dinis-RibeiroM. YaoK. Surveillance of patients with gastric precancerous conditions.Best Pract. Res. Clin. Gastroenterol.201630691392210.1016/j.bpg.2016.09.004 27938786
     [Google Scholar]
  6. ContiC.B. AgnesiS. ScaravaglioM. MasseriaP. DinelliM.E. OldaniM. UggeriF. Early gastric cancer: Update on prevention, diagnosis and treatment.Int. J. Environ. Res. Public Health2023203214910.3390/ijerph20032149 36767516
     [Google Scholar]
  7. XuW. LiB. XuM. YangT. HaoX. Traditional Chinese medicine for precancerous lesions of gastric cancer: A review.Biomed. Pharmacother.202214611254210.1016/j.biopha.2021.112542 34929576
     [Google Scholar]
  8. NagaokaA. SakuraiM. KamiieK. MasumiA. Sorghum (Sorghum bicolor) extract-induced adipogenesis is independent of PPARγ Ser273 phosphorylation in 3T3-L1 adipocytes.Biol. Pharm. Bull.202245565966310.1248/bpb.b22‑00087 35491170
     [Google Scholar]
  9. CrichtonM. DavidsonA.R. InnerarityC. MarxW. LohningA. IsenringE. MarshallS. Orally consumed ginger and human health: An umbrella review.Am. J. Clin. Nutr.202211561511152710.1093/ajcn/nqac035 35147170
     [Google Scholar]
  10. IsmailN.A. RafiiM.Y. MahmudT.M.M. HanafiM.M. MiahG. Molecular markers: A potential resource for ginger genetic diversity studies.Mol. Biol. Rep.201643121347135810.1007/s11033‑016‑4070‑3 27585572
     [Google Scholar]
  11. WangS. ZhangC. YangG. YangY. Biological properties of 6-gingerol: A brief review.Nat. Prod. Commun.2014971934578X140090010.1177/1934578X1400900736 25230520
     [Google Scholar]
  12. NogalesC. MamdouhZ.M. ListM. KielC. CasasA.I. SchmidtH.H.H.W. Network pharmacology: curing causal mechanisms instead of treating symptoms.Trends Pharmacol. Sci.202243213615010.1016/j.tips.2021.11.004 34895945
     [Google Scholar]
  13. YuanZ. PanY. LengT. ChuY. ZhangH. MaJ. MaX. Progress and prospects of research ideas and methods in the network pharmacology of traditional chinese medicine.J. Pharm. Pharm. Sci.20222521822610.18433/jpps32911 35760072
     [Google Scholar]
  14. KimS. Getting the most out of PubChem for virtual screening.Expert Opin. Drug Discov.201611984385510.1080/17460441.2016.1216967 27454129
     [Google Scholar]
  15. DainaA. MichielinO. ZoeteV. SwissTargetPrediction: Updated data and new features for efficient prediction of protein targets of small molecules.Nucleic Acids Res.201947W1W357W36410.1093/nar/gkz382 31106366
     [Google Scholar]
  16. RuJ. LiP. WangJ. ZhouW. LiB. HuangC. LiP. GuoZ. TaoW. YangY. XuX. LiY. WangY. YangL. TCMSP: A database of systems pharmacology for drug discovery from herbal medicines.J. Cheminform.2014611310.1186/1758‑2946‑6‑13 24735618
     [Google Scholar]
  17. KuhnM. SzklarczykD. FranceschiniA. CampillosM. von MeringC. JensenL.J. BeyerA. BorkP. STITCH 2: An interaction network database for small molecules and proteins.Nucleic Acids Res.201038Database issueSuppl. 1D552D55610.1093/nar/gkp937 19897548
     [Google Scholar]
  18. WuY. ZhangF. YangK. FangS. BuD. LiH. SunL. HuH. GaoK. WangW. ZhouX. ZhaoY. ChenJ. SymMap: An integrative database of traditional Chinese medicine enhanced by symptom mapping.Nucleic Acids Res.201947D1D1110D111710.1093/nar/gky1021 30380087
     [Google Scholar]
  19. GaoJ. YangS. XieG. PanJ. ZhuF. Integrating network pharmacology and experimental verification to explore the pharmacological mechanisms of aloin against gastric cancer.Drug Des. Devel. Ther.2022161947196110.2147/DDDT.S360790 35757520
     [Google Scholar]
  20. AmbergerJ.S. BocchiniC.A. SchiettecatteF. ScottA.F. HamoshA. OMIM.org: Online mendelian inheritance in man (OMIM®), an online catalog of human genes and genetic disorders.Nucleic Acids Res.201543D1D789D79810.1093/nar/gku1205 25428349
     [Google Scholar]
  21. SafranM. DalahI. AlexanderJ. RosenN. Iny SteinT. ShmoishM. NativN. BahirI. DonigerT. KrugH. Sirota-MadiA. OlenderT. GolanY. StelzerG. HarelA. LancetD. GeneCards version 3: The human gene integrator.Database20102010baq02010.1093/database/baq020 20689021
     [Google Scholar]
  22. PiñeroJ. BravoÀ. Queralt-RosinachN. Gutiérrez-SacristánA. Deu-PonsJ. CentenoE. García-GarcíaJ. SanzF. FurlongL.I. DisGeNET: A comprehensive platform integrating information on human disease-associated genes and variants.Nucleic Acids Res.201745D1D833D83910.1093/nar/gkw943 27924018
     [Google Scholar]
  23. TangD. ChenM. HuangX. ZhangG. ZengL. ZhangG. WuS. WangY. SRplot: A free online platform for data visualization and graphing.PLoS One20231811e029423610.1371/journal.pone.0294236 37943830
     [Google Scholar]
  24. MeringC. HuynenM. JaeggiD. SchmidtS. BorkP. SnelB. STRING: A database of predicted functional associations between proteins.Nucleic Acids Res.200331125826110.1093/nar/gkg034 12519996
     [Google Scholar]
  25. ZhouY. ZhouB. PacheL. ChangM. KhodabakhshiA.H. TanaseichukO. BennerC. ChandaS.K. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets.Nat. Commun.2019101152310.1038/s41467‑019‑09234‑6 30944313
     [Google Scholar]
  26. KanehisaM. FurumichiM. TanabeM. SatoY. MorishimaK. KEGG: New perspectives on genomes, pathways, diseases and drugs.Nucleic Acids Res.201745D1D353D36110.1093/nar/gkw1092 27899662
     [Google Scholar]
  27. WangY. ChuF. LinJ. LiY. JohnsonN. ZhangJ. GaiC. SuZ. ChengH. WangL. DingX. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.J. Ethnopharmacol.202127911439910.1016/j.jep.2021.114399 34246740
     [Google Scholar]
  28. SpohrP. DinklaK. KlauG.W. El-KebirM. eXamine: Visualizing annotated networks in Cytoscape.F1000 Res.2018751910.12688/f1000research.14612.2 29983924
     [Google Scholar]
  29. ZhangR. LiH. LiN. ShiJ.F. LiJ. ChenH.D. YuY.W. QinC. RenJ.S. ChenW.Q. HeJ. Risk factors for gastric cancer: A large-scale, population-based case-control study.Chin. Med. J.2021134161952195810.1097/CM9.0000000000001652 34310399
     [Google Scholar]
  30. LinS.H. LiY.H. LeungK. HuangC.Y. WangX.R. Salt processed food and gastric cancer in a Chinese population.Pac. J. Cancer.2014151352935298 25040991
     [Google Scholar]
  31. ZhangC. CaiT. ZengX. CaiD. ChenY. HuangX. GanH. ZhuoJ. ZhaoZ. PanH. LiS. Astragaloside IV reverses MNNG ‐induced precancerous lesions of gastric carcinoma in rats: R egulation on glycolysis through mi RNA ‐34a/LDHA pathway.Phytother. Res.20183271364137210.1002/ptr.6070 29577459
     [Google Scholar]
  32. WuZ. HuiJ. Crocin reverses 1-methyl-3-nitroso-1-nitroguanidine (MNNG)-induced malignant transformation in GES-1 cells through the Nrf2/Hippo signaling pathway.J. Gastrointest. Oncol.20201161242125210.21037/jgo‑20‑406 33456997
     [Google Scholar]
  33. ZhaoN. WangW. JiangH. QiaoZ. SunS. WeiY. XieX. LiH. BiX. YangZ. Natural products and gastric cancer: Cellular mechanisms and effects to change cancer progression.Anticancer. Agents Med. Chem.202323131506151810.2174/1871520623666230407082955 37026490
     [Google Scholar]
  34. BiW.P. ManH.B. ManM.Q. Efficacy and safety of herbal medicines in treating gastric ulcer: A review.World J. Gastroenterol.20142045170201702810.3748/wjg.v20.i45.17020 25493014
     [Google Scholar]
  35. SemwalR.B. SemwalD.K. CombrinckS. ViljoenA.M. Gingerols and shogaols: Important nutraceutical principles from ginger.Phytochemistry201511755456810.1016/j.phytochem.2015.07.012 26228533
     [Google Scholar]
  36. LiH. LiuY. LuoD. MaY. ZhangJ. LiM. YaoL. ShiX. LiuX. YangK. Ginger for health care: An overview of systematic reviews.Complement. Ther. Med.20194511412310.1016/j.ctim.2019.06.002 31331547
     [Google Scholar]
  37. Pal KaurI. Kaur DeolP. Kiran KondepudiK. BishnoiM. Anticancer potential of ginger: Mechanistic and pharmaceutical aspects.Curr. Pharm. Des.201622274160417210.2174/1381612822666160608115350 27290916
     [Google Scholar]
  38. KatzL. BaltzR.H. Natural product discovery: Past, present, and future.J. Ind. Microbiol. Biotechnol.2016432-315517610.1007/s10295‑015‑1723‑5 26739136
     [Google Scholar]
  39. ShizuyaT. MiyazakiS. Comparison of new drug indications approved in the United States, Europe, and Japan from 2001 to 2020.Biol. Pharm. Bull.202245101495150210.1248/bpb.b22‑00360 36184508
     [Google Scholar]
  40. CraneE.A. GademannK. Capturing biological activity in natural product fragments by chemical synthesis.Angew. Chem. Int. Ed.201655123882390210.1002/anie.201505863 26833854
     [Google Scholar]
  41. YangB. MaoJ. GaoB. LuX. Computer-assisted drug virtual screening based on the natural product databases.Curr. Pharm. Biotechnol.201920429330110.2174/1389201020666190328115411 30919773
     [Google Scholar]
  42. LiL. JiY. MaY.X. GaoL.Q. ZhouH.G. WuM.H. 6-Gingerol inhibits proliferation in gastric cancer via the STAT3 pathway in vitro.Cell. Mol. Biol.201965310911310.14715/cmb/2019.65.3.16 30942163
     [Google Scholar]
  43. LiY. LiT. ChenJ. ZhengH. LiY. ChuF. WangS. LiP. LinJ. SuZ. DingX. Manpixiao decoction halted the malignant transformation of precancerous lesions of gastric cancer: From network prediction to in-vivo verification.Front. Pharmacol.20221392773110.3389/fphar.2022.927731 35991884
     [Google Scholar]
  44. ErsahinT. TuncbagN. Cetin-AtalayR. The PI3K/AKT/mTOR interactive pathway.Mol. Biosyst.20151171946195410.1039/C5MB00101C 25924008
     [Google Scholar]
  45. LienE.C. DibbleC.C. TokerA. PI3K signaling in cancer: Beyond AKT.Curr. Opin. Cell Biol.201745627110.1016/j.ceb.2017.02.007 28343126
     [Google Scholar]
/content/journals/cchts/10.2174/0113862073303380240722112207
Loading
Effect and Mechanism of 6-Gingerol against Precancerous Lesions of Gastric Cancer Based on Network Pharmacology and In Vitro Experiment
Comb Chem High Throughput Screen 28, 2452 (2025); https://doi.org/10.2174/0113862073303380240722112207
/content/journals/cchts/10.2174/0113862073303380240722112207
/content/journals/cchts/10.2174/0113862073303380240722112207
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): 6-gingerol; experimental verification; gastric cancer; network pharmacology; pharmacological mechanisms; Precancerous lesions of gastric carcinoma

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test